Tag: preclinical data
August 21, 2019
Aptinyx Presents Data of NYX-458 in Preclinical Model of Head Injury
Aptinyx (NASDAQ:APTX) has announced presentation of preclinical data on its novel NMDA receptor modulator, NYX-458. As quoted in te press... June 21, 2019
Catabasis Pharmaceuticals Presents Preclinical Data of Edasalonexent
Catabasis Pharmaceuticals (NASDAQ:CATB) has announced preclinical data for its edasalonexent in Phase 2 development to treat Duchenne musclar dystrophy (DMD)....
May 24, 2018
Medicenna Receives Amendment to Revamp Clinical Trial
The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co....
May 23, 2018
Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO
The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which... May 10, 2018
Aptevo Therapeutics Reports First Quarter 2018 Financial Results
Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and... May 9, 2018
OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights
OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced first quarter 2018... May 8, 2018